Left ventricular assist devices: A rapidly evolving alternative to transplant

Journal of the American College of Cardiology

Volumn 65, Issue 23, 2015, Pages 2542-2555

  Mancini, Donna ^a   Colombo, Paolo C ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

heart assist devices; heart failure; heart transplantation

Indexed keywords

HORMONE ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; IVABRADINE; NEUROHORMONE ANTAGONIST; UNCLASSIFIED DRUG;

BLEEDING; CARDIAC GRAFT REJECTION; CARDIAC RESYNCHRONIZATION THERAPY; CENTRIFUGAL PUMP; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); DEVICE FAILURE; DEVICE THERAPY; DISEASE CLASSIFICATION; DONOR; DRIVELINE INFECTION; GERIATRIC PATIENT; GRAFT SURVIVAL; HEALTH CARE AVAILABILITY; HEART FAILURE; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MORBIDITY; MORTALITY; ORGAN DONOR SHORTAGE; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMOTE SENSING; REVIEW; SEPSIS; SOCIAL SUPPORT; SURVIVAL TIME; THROMBUS; HEART ASSIST DEVICE; HEART VENTRICLE; PROSTHESIS; STANDARDS; TRENDS;

CLINICAL TRIALS AS TOPIC; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; PROSTHESIS DESIGN;

EID: 84930694859     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.04.039     Document Type: Review

References (76)

1. V.L. Roger Epidemiology of heart failure Circ Res 113 2013 646 659
2. E. Braunwald The war against heart failure: the Lancet lecture Lancet 385 2015 812 824
3. K. Smolina, F.L. Wright, and M. Rayner Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study BMJ 344 2012 d8059
4. M. Jessup Neprilysin inhibition - a novel therapy for heart failure N Engl J Med 371 2014 1062 1064
5. K. Swedberg, M. Komajda, M. Bohm for the SHIFT Investigators Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Lancet 376 2010 875 885
6. J.J.V. McMurray, M. Packer, A.S. Desai for the PARADIGM-HF Investigators and Committees Angiotensin-neprilysin inhibition versus enalapril in heart failure N Engl J Med 371 2014 993 1004
7. M.S. Slaughter, J.G. Rogers, C.A. Milano for the HeartMate II Investigators Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
8. L.W. Miller, F.D. Pagani, S.D. Russell for the HeartMate II Clinical Investigators Use of a continuous-flow device in patients awaiting heart transplantation N Engl J Med 357 2007 885 896
9. K.D. Aaronson, M.S. Slaughter, L.W. Miller for the HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation Circulation 125 2012 3191 3200
10. J.A. Kirk, and D.A. Kass Electromechanical dyssynchrony and resynchronization of the failing heart Circ Res 113 2013 765 776
11. D. Feldman, S.V. Pamboukian, and J.J. Teuteberg The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary J Heart Lung Transplant 32 2013 157 187
12. D. Mancini, and K. Lietz Selection of cardiac transplantation candidates in 2010 Circulation 122 2010 173 183
13. J. Stehlik, L.B. Edwards, and A.Y. Kucheryavaya The Registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report - 2011 J Heart Lung Transplant 30 2011 1078 1094
14. U.S. Department of Health and Human Services. Organ Procurement and Transplantation Network. Available at: http://optn.transplant.hrsa.gov. Accessed April 24, 2015.
15. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR) Heart OPTN/SRTR 2010 Annual Data Report 2011 Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation Rockville, MD 89 116
16. U.S. Department of Health and Human Services. Chapter VI: heart transplantation in the US 1999-2008. In: 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008. Rockville, MD: U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation. Available at: http://www.srtr.org/annual-reports/archives/2009/2009-Annual-Report/. Accessed April 24, 2015.
17. A. Ardehali, F. Esmailian, M. Deng for the PROCEED II Trial Investigators Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial Lancet 2015 April 14 [E-pub ahead of print]
18. K.K. Dhital, A. Iyer, and M. Connellan Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series Lancet 2015 April 14 [E-pub ahead of print]
19. E.A. Rose, A.C. Gelijns, A.J. Moskowitz for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
20. J.C. Matthews, T.M. Koelling, and F.D. Pagani The right ventricular failure risk score: a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates J Am Coll Cardiol 51 2008 2163 2172
21. J.R. Fitzpatrick 3rd, J.R. Frederick, and V.M. Hsu Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support J Heart Lung Transplant 27 2008 1286 1292
22. R.L. Kormos, J.J. Teuteberg, F.D. Pagani for the HeartMate II Clinical Investigators Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes J Thorac Cardiovasc Surg 139 2010 1316 1324
23. E.V. Potapov, A. Stepanenko, and M. Dandel Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device J Heart Lung Transplant 27 2008 1275 1281
24. M. Kukucka, A. Stepanenko, and E. Potapov Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices J Heart Lung Transplant 30 2011 64 69
25. T.S. Kato, J. Jiang, and P.C. Schulze Serial echocardiography using tissue Doppler and speckle tracking imaging to monitor right ventricular failure before and after left ventricular assist device surgery J Am Coll Cardiol HF 1 2013 216 222
26. S.G. Drakos, L. Janicki, and B.D. Horne Risk factors predictive of right ventricular failure after left ventricular assist device implantation Am J Cardiol 105 2010 1030 1035
27. M.S. Slaughter, F.D. Pagani, J.G. Rogers for the HeartMate II Clinical Investigators Clinical management of continuous-flow left ventricular assist devices in advanced heart failure J Heart Lung Transplant 29 4 Suppl 2010 S1 S39
28. S. Hayek, D.B. Sims, D.W. Markham, J. Butler, and A.P. Kalogeropoulos Assessment of right ventricular function in left ventricular assist device candidates Circ Cardiovasc Imaging 7 2014 379 389
29. J.L. Peura, M. Colvin-Adams, G.S. Francis American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation Council on Cardiovascular Disease in the Young Council on Cardiovascular Nursing Council on Cardiovascular Radiology and Intervention; and Council on Cardiovascular Surgery and Anesthesia Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association Circulation 126 2012 2648 2667
30. M.R. Mehra, J. Kobashigawa, and R. Starling Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006 J Heart Lung Transplant 25 2006 1024 1042
31. J.K. Kirklin, D.C. Naftel, and J.W. Kirklin Pulmonary vascular resistance and the risk of heart transplantation J Heart Transplant 7 1988 331 336
32. D. Zimpfer, P. Zrunek, and S. Sandner Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices Eur J Cardiothorac Surg 31 2007 698 702
33. C.D. Etz, H.A. Welp, and T.D. Tjan Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices Ann Thorac Surg 83 2007 1697 1705
34. E.S. Weiss, L.U. Nwakanma, and N.D. Patel Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database J Heart Lung Transplant 27 2008 184 191
35. J.A. Morgan, R. John, and A.D. Weinberg Long-term results of cardiac transplantation in patients 65 years of age and older: a comparative analysis Ann Thorac Surg 76 2003 1982 1987
36. R.A. Sorabella, H. Yerebakan, and R. Walters Comparison of outcomes after heart replacement therapy in patients over 65 years old Ann Thorac Surg 99 2015 582 588
37. J.C. Matthews, F.D. Pagani, and J.W. Haft Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality Circulation 121 2010 214 220
38. J.A. Yang, T.S. Kato, and B.P. Shulman Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system J Heart Lung Transplant 31 2012 601 610
39. J. Cowger, K. Sundareswaran, and J.G. Rogers Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score J Am Coll Cardiol 61 2013 313 321
40. S.S. Thomas, N. Nahumi, and J. Han Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score J Heart Lung Transplant 33 2014 675 681
41. J.K. Kirklin, D.C. Naftel, and F.D. Pagani Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg 144 2012 584 603 discussion 597-8
42. J.A. Yang, K. Takeda, and Y. Naka Evolution of status 1A heart transplant candidates (abstr) J Heart Lung Transplant 34 2015 S155 S156
43. J.G. Rogers, J. Butler, S.L. Lansman for the INTrEPID Investigators Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial J Am Coll Cardiol 50 2007 741 747
44. R.C. Starling, Y. Naka, and A.J. Boyle Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) J Am Coll Cardiol 57 2011 1890 1898
45. U.P. Jorde, S.S. Kushwaha, A.J. Tatooles for the HeartMate II Clinical Investigators Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support) J Am Coll Cardiol 63 2014 1751 1757
46. J.K. Kirklin, D.C. Naftel, and F.D. Pagani Sixth INTERMACS annual report: a 10,000-patient database J Heart Lung Transplant 33 2014 555 564
47. ClinicalTrials.gov. Risk assessment and comparative effectiveness of left ventricular assist device (LVAD) and medical management (ROADMAP). 2015. Available at: https://clinicaltrials.gov/ct2/show/NCT01452802. Accessed April 25, 2015.
48. J.D. Estep, R.C. Starling, and D.A. Horstmanshof Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients (ROADMAP) J Heart Lung Transplant 34 2015 S80
49. J.T. Baldwin, and D.L. Mann NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial J Card Fail 16 2010 855 858
50. N. Uriel, S.W. Pak, and U.P. Jorde Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation J Am Coll Cardiol 56 2010 1207 1213
51. U.P. Jorde, N. Uriel, and N. Nahumi Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients Circ Heart Fail 7 2014 310 319
52. R.C. Starling, N. Moazami, and S.C. Silvestry Unexpected abrupt increase in left ventricular assist device thrombosis N Engl J Med 370 2014 33 40
53. M.E. Nassif, J.S. Patel, and J.E. Shuster Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device J Am Coll Cardiol HF 3 2015 146 153
54. N. Uriel, J. Han, and K.A. Morrison Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon J Heart Lung Transplant 33 2014 51 59
55. M.R. Mehra, G.C. Stewart, and P.A. Uber The vexing problem of thrombosis in long-term mechanical circulatory support J Heart Lung Transplant 33 2014 1 11
56. F.D. Pagani Continuous-flow rotary left ventricular assist devices with "3rd generation" design Semin Thorac Cardiovasc Surg 20 2008 255 263
57. S. Lee, K. Fukamachi, and L. Golding Left ventricular assist devices: from the bench to the clinic Cardiology 125 2013 1 12
58. G.A. Giridharan, S.C. Koenig, and K.G. Soucy Left ventricular volume unloading with axial and centrifugal rotary blood pumps ASAIO J 61 2015 292 300
59. Z.T. Demirozu, R. Radovancevic, and L.F. Hochman Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device J Heart Lung Transplant 30 2011 849 853
60. N. Moazami, W.P. Dembitsky, and R. Adamson Does pulsatility matter in the era of continuous-flow blood pumps? J Heart Lung Transplant 2014 Sep 28 [E-pub ahead of print]
61. K.G. Soucy, G.A. Giridharan, and Y. Choi Rotary pump speed modulation for generating pulsatile flow and phasic left ventricular volume unloading in a bovine model of chronic ischemic heart failure J Heart Lung Transplant 34 2015 122 131
62. S.W. Pak, N. Uriel, and H. Takayama Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices J Heart Lung Transplant 29 2010 1172 1176
63. S.S. Asgari, and P. Bonde Implantable physiologic controller for left ventricular assist devices with telemetry capability J Thorac Cardiovasc Surg 147 2014 192 202
64. A.M. Bernhardt, T.M. De By, and H. Reichenspurner Isolated permanent right ventricular assist device implantation with the HeartWare continuous-flow ventricular assist device: first results from the European Registry for Patients with Mechanical Circulatory Support Eur J Cardiothorac Surg 2014 Oct 29 [E-pub ahead of print]
65. E.J. Birks, P.D. Tansley, and J. Hardy Left ventricular assist device and drug therapy for the reversal of heart failure N Engl J Med 355 2006 1873 1884
66. E.J. Birks, R.S. George, and M. Hedger Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study Circulation 123 2011 381 390
67. M.A. Simon, R.L. Kormos, and S. Murali Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes Circulation 112 2005 I32 I36
68. D.M. Mancini, A. Beniaminovitz, and H. Levin Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure Circulation 98 1998 2383 2389
69. M.H. Yacoub A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery Eur Heart J 22 2001 534 540
70. S.G. Drakos, A.G. Kfoury, and J. Stehlik Bridge to recovery: understanding the disconnect between clinical and biological outcomes Circulation 126 2012 230 241
71. S.R. Patel, O. Saeed, and S. Murthy Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study J Heart Lung Transplant 32 2013 305 312
72. K.D. Aaronson, F.D. Pagani, and S.W. Maybaum 3 combination therapy with pulsatile left ventricular assist device, heart failure medication and clenbuterol in chronic heart failure: results from HARPS (abstr) J Heart Lung Transplant 30 2013 58 59
73. M. Dandel, Y. Weng, and H. Siniawski Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices Eur Heart J 32 2011 1148 1160
74. S.G. Drakos, J.V. Terrovitis, and M.I. Anastasiou-Nana Reverse remodeling during long-term mechanical unloading of the left ventricle J Mol Cell Cardiol 43 2007 231 242
75. D.D. Ascheim, A.C. Gelijns, and D. Goldstein Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices Circulation 129 2014 2287 2296
76. J.K. Kirklin, D.C. Naftel, and R.L. Kormos Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device J Heart Lung Transplant 33 2014 12 22